Mestron has not obtain any approval or clearance from the Ministry of Health to purchase or distribute Covid-19 vaccines in Malaysia. 2. Mestron intention is to explore and venture into vaccine distribution business by partnering with Zhongyu Yexing (Chengdu) Industrial Co., Ltd. (“Zhongyu”) (“中宇晔兴(成都)实业有限公司”). Zhongyu is part of Sino Pharma Group of Companies (“Sinopharm”) (“中国医药 集团有限公司”). It is mainly involved in the sale, distribution, marketing and promotion of the Covid-19 vaccine and other medical and pharmaceutical products. It is one of the authorised distributor for Sinopharm’s China National Biotech Group (“CNBG”) Covid-19 vaccine. Pa
Changes in Director's Interest (Section 219 of CA 2016) DATUK IR MOHD DOM BIN AHMAD Disposal of 2,000,000 ordinary shares via open market transaction RM0.215 29/01/2021.
Mestron should test 0.14 first before ascending again. I will wait. Patience and profit. Every stock have its up and down. No need to chase unless you are good in technical analysis
Agree, me also have to cut loss first. I'm very disappointed with top management, they seems eager to announce something without considering all the requirement and sensitivity about vaccines. No ethic, no integrity and no basic understanding in handling business at high level.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
duitKWSPkita
26,756 posts
Posted by duitKWSPkita > 2021-02-02 08:56 | Report Abuse
Suspended to save life